Navigation Links
Almac has Successful MHRA Inspection at its Clinical Services UK Site
Date:10/17/2010

Almac has Successful MHRA Inspection at its Clinical Services UK Site -- CRAIGAVON, Northern Ireland, October 18, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biometrics, Biotechnology, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Corporate Expansion, New Products & Services, European Government Click to view news release full screen  

Almac has Successful MHRA Inspection at its Clinical Services UK Site

 

CRAIGAVON, Northern Ireland, October 18, 2010 /PRNewswire/ -- Almac is once again pleased to announce the successful completion of an inspection of its Clinical Services UK facility located in Craigavon by the Medicines and Healthcare products Regulatory Agency (MHRA).

The routine inspection, which took place over four days, from September 13th - September 16th, was conducted by a MHRA inspector who concluded that the site continues to be compliant with EU Good Manufacturing Practices, with no critical or major failures observed.

Commenting on the inspection, Paul O'Connor (Vice President, Quality), said:

"We are extremely pleased with the outcome of our inspection. These successful results are a positive reflection of all the investment Almac has made over the past few years in our facilities and recruitment of the best employees, ensuring that we are a market leader and continue to deliver a high quality service. Quality is at the core of our ethos - we have three MHRA approved facilities globally, including our additional FDA assessed US facilities in Audubon, Pennsylvania and Durham, North Carolina. The very high standards of quality compliance will continue with our new $120 million North American Headquarters in Souderton - scheduled to open during the autumn."

Notes to Editors

About Almac:

The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS technology (IVRS/IWRS), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors.

The company employs over 2,800 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Almac has officially gained full possession of its new $120m North American Headquarters, which started in July 2008, and employees will relocate during the fall.

For more information on Almac, please visit http://www.almacgroup.com Contact: Aileen Murphy aileen.murphy@almacgroup.com Tel: +44(0)28-3836-2436
'/>"/>

SOURCE Almac Group
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. University of Nevada, Reno, demonstrates successful sludge-to-power research
2. University of Nevada, Reno demonstrates successful sludge-to-power research
3. New method successfully predicted how oil from Deepwater Horizon spill would spread
4. School-based intervention successfully lowers drinking rates in at risk children
5. Scientists successfully use human induced pluripotent stem cells to treat Parkinsons in rodents
6. Pitt researcher says simple polymer-based filter successfully cleans water, recovers oil in Gulf of Mexico tests
7. Polymer-based filter successfully cleans water, recovers oil in Gulf of Mexico test
8. Cell Transplantation reports consistent and successful islet isolations offer diabetes hope
9. Novel protein essential for successful pregnancy
10. Successful launch for ESAs CryoSat-2 ice satellite
11. Successful genome sequencing of pea aphid is a breakthrough for ecology and agricultural research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
(Date:4/11/2017)... GARDENS, Fla. , April 11, 2017 /PRNewswire/ ... management and secure authentication solutions, today announced that ... by Intelligence Advanced Research Projects Activity (IARPA) to ... IARPA,s Thor program. "Innovation has been ... and IARPA,s Thor program will allow us to ...
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
Breaking Biology News(10 mins):
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... research organization (CRO) has validated a 0.2 ng/mL lower limit (LLOQ) assay for ... a 0.5 ng/mL LLOQ assay, the ultra-low trace nicotine assay meets additional needs ...
(Date:4/27/2017)... ... April 27, 2017 , ... Mitotech S.A, a Luxembourg ... Hereditary Optic Neuropathy (LHON) patients. LHON is a rare devastating genetic disease that leads ... eye drops in a group of 20 patients carrying 11778, 14484 and 3460 mutations ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... flow controllers based on capillary thermal mass flow technology provide exponentially more accurate ... applications. Over 80% of all industrial processes—such as those involving chemical reactions, ...
(Date:4/27/2017)...  Pendant Biosciences, Inc. (formerly Nanoferix, Inc.), a privately-held ... delivery technologies, today announced that it has been accepted ... Toronto . Shawn Glinter , ... "We are excited to become part of the JLABS ... honored to be the first Tennessee ...
Breaking Biology Technology: